Cigna Group $CI Stake Increased by Brandes Investment Partners LP

Brandes Investment Partners LP increased its stake in shares of Cigna Group (NYSE:CIFree Report) by 14.0% during the fourth quarter, HoldingsChannel.com reports. The firm owned 944,262 shares of the health services provider’s stock after buying an additional 115,857 shares during the period. Cigna Group accounts for 2.0% of Brandes Investment Partners LP’s portfolio, making the stock its 8th largest position. Brandes Investment Partners LP’s holdings in Cigna Group were worth $259,892,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Beacon Financial Strategies CORP purchased a new stake in Cigna Group during the 4th quarter worth about $28,000. Lodestone Wealth Management LLC bought a new stake in shares of Cigna Group during the 4th quarter valued at about $32,000. Creative Financial Designs Inc. ADV boosted its position in shares of Cigna Group by 147.3% during the 4th quarter. Creative Financial Designs Inc. ADV now owns 136 shares of the health services provider’s stock valued at $37,000 after acquiring an additional 81 shares during the last quarter. Activest Wealth Management boosted its position in shares of Cigna Group by 1,050.0% during the 4th quarter. Activest Wealth Management now owns 138 shares of the health services provider’s stock valued at $38,000 after acquiring an additional 126 shares during the last quarter. Finally, Entrust Financial LLC bought a new stake in shares of Cigna Group during the 4th quarter valued at about $42,000. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Cigna Group Stock Performance

Shares of NYSE CI opened at $294.77 on Wednesday. The stock has a market cap of $77.97 billion, a price-to-earnings ratio of 12.50, a P/E/G ratio of 1.12 and a beta of 0.28. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.69. Cigna Group has a 1-year low of $239.51 and a 1-year high of $338.89. The stock’s 50-day moving average is $280.60 and its 200 day moving average is $277.57.

Cigna Group (NYSE:CIGet Free Report) last announced its quarterly earnings data on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, beating analysts’ consensus estimates of $7.60 by $0.19. The company had revenue of $68.52 billion for the quarter, compared to analysts’ expectations of $66.29 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.Cigna Group’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same period last year, the firm posted $6.74 EPS. Cigna Group has set its FY 2026 guidance at 30.350- EPS. On average, sell-side analysts anticipate that Cigna Group will post 30.39 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, June 18th. Shareholders of record on Thursday, June 4th will be paid a $1.56 dividend. This represents a $6.24 dividend on an annualized basis and a yield of 2.1%. The ex-dividend date of this dividend is Thursday, June 4th. Cigna Group’s payout ratio is 26.45%.

Analysts Set New Price Targets

A number of analysts have recently issued reports on the company. Piper Sandler dropped their price target on Cigna Group from $370.00 to $346.00 and set an “overweight” rating for the company in a research report on Wednesday, June 3rd. Deutsche Bank Aktiengesellschaft downgraded Cigna Group from a “buy” rating to a “hold” rating and dropped their price target for the company from $303.00 to $302.00 in a research report on Wednesday, May 20th. Robert W. Baird set a $337.00 price target on Cigna Group in a research report on Friday, May 1st. Truist Financial lifted their price target on Cigna Group from $320.00 to $350.00 and gave the company a “buy” rating in a research report on Tuesday, February 17th. Finally, Raymond James Financial set a $340.00 price target on Cigna Group in a research report on Friday, May 1st. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and six have given a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $338.80.

Check Out Our Latest Analysis on CI

Insider Buying and Selling

In other Cigna Group news, CEO David Cordani sold 201,878 shares of Cigna Group stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total value of $59,113,915.96. Following the transaction, the chief executive officer directly owned 34,337 shares of the company’s stock, valued at $10,054,560.34. The trade was a 85.46% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is owned by company insiders.

About Cigna Group

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Recommended Stories

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.